A multicentre study of the risk factors associated with recurrence of central serous chorioretinopathy.
Xiaoyin ZhouYuki YamamotoTakashi ArakiKenta HozumiHiroto TerasakiAkiko MikiSoichiro KuwayamaMasanori NikiHisashi MatsubaraTakamasa KinoshitaTomo NishiFumi GomiPublished in: Acta ophthalmologica (2022)
Patients with CSC who received corticosteroids and had bilateral disease, chronic manifestation, non-intense fluorescein leakage on fluorescein angiography or a relatively thinner CRT should be closely monitored to identify whether they are at high risk of recurrence.